CELU
Celularity Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Robert Joseph Hariri
IPO Date
2019-08-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Celularity Inc.
CEO
Robert Joseph Hariri
IPO Date
2019-08-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 839,160 |
| $2.00 |
| 24 Apr 2026 | Barach Daniele Wolf | 10 percent owner | Disposed | 1,204,819 | $1.66 |
| 24 Apr 2026 | Barach Daniele Wolf | 10 percent owner | Disposed | 839,160 | $2.00 |
| 24 Apr 2026 | Philip & Daniele Barach Family Trust | 10 percent owner | Disposed | 1,204,819 | $1.66 |
| 24 Apr 2026 | Philip & Daniele Barach Family Trust | 10 percent owner | Disposed | 839,160 | $2.00 |
| 15 Apr 2026 | Brigido Stephen | Pres., Functional Regeneration | M-Exempt | Acquired | 821 | $0.00 |
| 15 Apr 2026 | Brigido Stephen | Pres., Functional Regeneration | F-InKind | Disposed | 268 | $1.28 |
| 15 Apr 2026 | Brigido Stephen | Pres., Functional Regeneration | M-Exempt | Disposed | 821 | $0.00 |
| 15 Apr 2026 | Haines John R | Senior Exec Vice President | M-Exempt | Acquired | 1,641 | $0.00 |